๐ Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.
The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3-23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins.
keywords
๐ *COVID-19 (1240)
๐ *SARS-CoV-2 (551)
๐ *antibodies (608)
๐ *coronavirus (5664)
๐ *humoral immunity ()
๐ *immunofluorescence assay ()
๐ *microneutralisation test ()
๐ *western blotting (5)
๐ *whole-genome sequencing ()
๐ spike protein (353)
๐ virus strain (138)
author
๐ค Haveri, Anu
๐ค Smura, Teemu
๐ค Kuivanen, Suvi
๐ค Osterlund, Pamela
๐ค Hepojoki, Jussi
๐ค Ikonen, Niina
๐ค Pitkapaasi, Marjaana
๐ค Blomqvist, Soile
๐ค Ronkko, Esa
๐ค Kantele, Anu
๐ค Strandin, Tomas
๐ค Kallio-Kokko, Hannimari
๐ค Mannonen, Laura
๐ค Lappalainen, Maija
๐ค Broas, Markku
๐ค Jiang, Miao
๐ค Siira, Lotta
๐ค Salminen, Mika
๐ค Puumalainen, Taneli
๐ค Sane, Jussi
๐ค Melin, Merit
๐ค Vapalahti, Olli
๐ค Savolainen-Kopra, Carita
year
โฐ 2020
journal
๐ Euro Surveill
issn
๐
volume
number
page
citedbycount
0
download
๐ [BibTeX]